<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5454912</article-id><article-id pub-id-type="doi">10.3390/ijms18050999</article-id><article-id pub-id-type="publisher-id">ijms-18-00999</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Incomplete Segregation of MSH6 Frameshift Variants with Phenotype of Lynch Syndrome </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liccardo</surname><given-names>Raffaella</given-names></name><xref ref-type="aff" rid="af1-ijms-18-00999">1</xref></contrib><contrib contrib-type="author"><name><surname>De Rosa</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="af1-ijms-18-00999">1</xref></contrib><contrib contrib-type="author"><name><surname>Rossi</surname><given-names>Giovanni Battista</given-names></name><xref ref-type="aff" rid="af2-ijms-18-00999">2</xref></contrib><contrib contrib-type="author"><name><surname>Carlomagno</surname><given-names>Nicola</given-names></name><xref ref-type="aff" rid="af3-ijms-18-00999">3</xref></contrib><contrib contrib-type="author"><name><surname>Izzo</surname><given-names>Paola</given-names></name><xref ref-type="aff" rid="af1-ijms-18-00999">1</xref><xref ref-type="aff" rid="af4-ijms-18-00999">4</xref></contrib><contrib contrib-type="author"><name><surname>Duraturo</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="af1-ijms-18-00999">1</xref><xref rid="c1-ijms-18-00999" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Kuppen</surname><given-names>Peter J.K.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-18-00999"><label>1</label>Department of Molecular Medicine and Medical Biotechnology, Federico II University Medical School, 80131 Naples, Italy; <email>liccardo@dbbm.unina.it</email> (R.L.); <email>marina.derosa@unina.it</email> (M.D.R.); <email>paola.izzo@unina.it</email> (P.I.)</aff><aff id="af2-ijms-18-00999"><label>2</label>Endoscopy Unit, Fondazione Pascale National Institute for Study and Care of Tumors, 80131 Naples, Italy; <email>giorossi.alice@alice.it</email></aff><aff id="af3-ijms-18-00999"><label>3</label>General Surgery Unit—Advanced Biomedical Science Department, Federico II University Medical School, 80131 Naples, Italy; <email>nicola.anita@tiscali.it</email></aff><aff id="af4-ijms-18-00999"><label>4</label>CEINGE-Biotecnologie Avanzate, 80145 Naples, Italy</aff><author-notes><corresp id="c1-ijms-18-00999"><label>*</label>Correspondence: <email>duraturo@dbbm.unina.it</email> or <email>francesca.duraturo@unina.it</email>; Tel.: +39-0817-463-136; Fax: +39-0817-464-359</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2017</year></pub-date><volume>18</volume><issue>5</issue><elocation-id>999</elocation-id><history><date date-type="received"><day>03</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>02</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>© 2017 by the authors.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>Lynch syndrome (LS), the most frequent form of hereditary colorectal cancer, involves mutations in mismatch repair genes. </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to identify mutations in MSH6 from 97 subjects negative for mutations in MLH1 and MSH2. </plain></SENT>
<SENT sid="3" pm="."><plain>By direct sequencing, we identified 27 MSH6 variants, of which, nine were novel. </plain></SENT>
<SENT sid="4" pm="."><plain>To verify the pathogenicity of these novel variants, we performed in silico and segregation analyses. </plain></SENT>
<SENT sid="5" pm="."><plain>Three novel variants were predicted by in silico analysis as damaging mutations and segregated with the disease phenotype; while a novel frameshift deletion variant that was predicted to yield a premature stop codon did not segregate with the LS phenotype in three of four cases in the family. </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, another frame-shift variant identified in this study, already described in the literature, also did not segregate with the LS phenotype in one of two affected subjects in the family. </plain></SENT>
<SENT sid="7" pm="."><plain>In all affected subjects of both families, no mutation was detected in other MMR genes. </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore, it is expected that within these families, other genetic factors contribute to the disease either alone or in combination with MSH6 variants. </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that caution should be exercised in counseling for MSH6-associated LS family members. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>Lynch syndrome</kwd><kwd>segregation analysis</kwd><kwd><italic>MSH6</italic> gene</kwd><kwd>hereditary colorectal cancer</kwd><kwd>oligogenic model</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec id="sec1-ijms-18-00999"><title><text><SENT sid="10" pm="."><plain>1. </plain></SENT>
<SENT sid="11" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="12" pm="."><plain>Lynch syndrome (LS) is the most common form of hereditary colorectal cancer (CRC) with an incidence of 3–5% among all cases of CRC, whereas its main genetic counterparts, familial adenomatous polyposis (FAP) and MYH-associated polyposis (MAP) syndromes, account for 1% of CRC diagnoses [1,2,3]. </plain></SENT>
<SENT sid="13" pm="."><plain>The main clinical manifestation of LS is the development of colon cancer on average around 45 years; this syndrome is also characterized by an increased risk of developing extra-colonic tumors, such as endometrial cancer, ovarian, stomach, urinary and biliary tract. </plain></SENT>
<SENT sid="14" pm="."><plain>Germline mutations in the DNA mismatch repair (MMR) genes are responsible for the LS phenotype [1]. </plain></SENT>
<SENT sid="15" pm="."><plain>Germline mutations in MLH1 and MSH2 account for about 40% and 39%, respectively, of all LS-associated mutations [4]. </plain></SENT>
<SENT sid="16" pm="."><plain>Approximately 10–20% of the mutations in MMR genes have been identified in MSH6 and PMS2 genes [5]; moreover, mutations in MLH3 and MSH3 genes [6,7] associated with LS phenotype were also reported. </plain></SENT>
<SENT sid="17" pm="."><plain>These mutations determine the loss of function of the MMR complex that, at the somatic level, is manifest as high levels of microsatellite instability (MSI), which occurs in &gt;90% of all LS carcinomas [8]. </plain></SENT>
<SENT sid="18" pm="."><plain>The lost expression of the affected protein, at the somatic level, is also detectable by immunohistochemistry (IHC) analysis [9]. </plain></SENT>
<SENT sid="19" pm="."><plain>Identification of families affected by LS occurs by the Amsterdam Criteria (AC) and Bethesda Guidelines (BG) [10,11,12]. </plain></SENT>
</text></p><p><text><SENT sid="20" pm="."><plain>Identifying carriers of MMR mutations is critical for improving cancer surveillance and prevention. </plain></SENT>
<SENT sid="21" pm="."><plain>Until a few years ago, genetic testing was performed only for MLH1 and MSH2; when these were negative, mutations in MSH6 were investigated [4]. </plain></SENT>
<SENT sid="22" pm="."><plain>Recent guidelines recommend testing the tumors of all patients with CRC with either IHC or for MSI to identify potential cases of LS; moreover, all patients meeting AC or BL should be offered germline genetic testing for mutations in MLH1, MSH2, MSH6 and PMS2 [13]. </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>MSH6 is located on chromosome 2p16, near MSH2 [14,15], and can cause an LS phenotype, although germline mutations have been attributed to families with incomplete penetrance, delayed cancer onset and low MSI [16,17,18]. </plain></SENT>
<SENT sid="24" pm="."><plain>Detecting mutations in MMR genes has been mainly carried out in Lynch patients with tumors with high MSI, which may explain the lower frequency of observed mutations in MSH6. </plain></SENT>
<SENT sid="25" pm="."><plain>Moreover, mutations in MSH6 confer a relatively greater risk of endometrial cancer [19,20]. </plain></SENT>
<SENT sid="26" pm="."><plain>The aim of this study was to investigate the contribution of mutations in MSH6 in 97 CRC patients belonging to 74 Lynch families, already negative for germline mutations in MLH1 and MSH2. </plain></SENT>
<SENT sid="27" pm="."><plain>We report several molecular variants in our Lynch patients, of which nine are novel variants. </plain></SENT>
<SENT sid="28" pm="."><plain>Moreover, we describe two Lynch families in which MSH6 variants do not fully segregate with the cancer phenotype and discuss the clinical implications of this finding. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS"><sec id="sec2-ijms-18-00999"><title><text><SENT sid="29" pm="."><plain>2. </plain></SENT>
<SENT sid="30" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="31" pm="."><plain>All MSH6 exons were analyzed on DNA extracted from 97 CRC patients belonging to 74 families selected by the AC and BG. </plain></SENT>
<SENT sid="32" pm="."><plain>As shown in Table 1, 27 germline variants were identified in MSH6, nine of which were novel variants not previously reported in the NCBI SNP database, the Human Gene Mutation Database (available online: http://www.hgmd.cf.ac.uk/ac/index.php), the International Society for Gastrointestinal Hereditary Tumors (InSight; available online: http://www.insightgroup.org/) or the MMR variants database [21]. </plain></SENT>
<SENT sid="33" pm="."><plain>MSI analysis was performed for all patients with available paraffin-embedded tumor tissues; these results are listed in Table 1. </plain></SENT>
</text></p><p><text><SENT sid="34" pm="."><plain>Missense mutations (30%) and intronic alterations (30%) were the most common aberrations. </plain></SENT>
<SENT sid="35" pm="."><plain>The other observed mutations were silent variants (26%), frame-shift variants (7%) and an in-frame insertion of three nucleotides (4%). </plain></SENT>
<SENT sid="36" pm="."><plain>Details on the prevalence of each variant are given in Table 1. </plain></SENT>
<SENT sid="37" pm="."><plain>The nine novel DNA variants were not detected in the 100 healthy controls from Southern Italy (Table 2). </plain></SENT>
<SENT sid="38" pm="."><plain>To verify the pathogenicity of the novel variants, we used a combination of computational and segregation analyses, as described in our previous studies [7,21]. </plain></SENT>
<SENT sid="39" pm="."><plain>The results are shown in Table 2. </plain></SENT>
</text></p><p><text><SENT sid="40" pm="."><plain>Computational analysis, in particular HSF, showed significant results for all novel variants identified in this study; while the segregation analysis (done only for 4/9 novel variants) did not always confirm the pathogenicity. </plain></SENT>
<SENT sid="41" pm="."><plain>The novel variants, c.457+33_+34insGTGT, c.2049_2050insAGT and c.2941A&gt;G, segregated with the LS phenotype in the family (Figure 1). </plain></SENT>
<SENT sid="42" pm="."><plain>In contrast, the novel variant c.3296_97delTT in exon 5 of MSH6, identified in the index case No. 105 (Table 2), did not segregate with disease in the family (Figure 2a). </plain></SENT>
<SENT sid="43" pm="."><plain>However, this variant was a frameshift mutation that produced a premature stop codon, resulting in a truncated protein; therefore, it would be considered a pathogenic variant. </plain></SENT>
<SENT sid="44" pm="."><plain>This variant was not identified in the other affected family members that met the AC (Table 2); MSI testing performed on DNA extracted from tumor tissue of the index case showed an MSI-high (H) status, but MSI-H was also identified in tumor DNA from Subject II:6 who was not a carrier of this variant (Figure 2a). </plain></SENT>
<SENT sid="45" pm="."><plain>The other affected subjects from this family II:1 and II:3 were not carriers of this variant (Figure 2a). </plain></SENT>
</text></p><p><text><SENT sid="46" pm="."><plain>Interestingly, we identified another frameshift variant in exon 5 of MSH6, c.3261dup, that also produced an early stop codon and a truncated protein. </plain></SENT>
<SENT sid="47" pm="."><plain>This variant was already reported in the literature [22] and was classified as Class 5 in the Insight database. </plain></SENT>
<SENT sid="48" pm="."><plain>In our study, this variant was identified in the index case No. 103, a patient that developed CRC at age 61 (Figure 2b). </plain></SENT>
<SENT sid="49" pm="."><plain>MSI analysis showed an MSI-low (L); IHC showed the absence of MSH6 protein in tumor tissue (Figure 3), but segregation analysis showed that the variant was not present in the sister (II:4) of the index case, who also developed two colon adenomas, one of which with severe dysphasia (Figure 2b). </plain></SENT>
<SENT sid="50" pm="."><plain>We did not analyze other affected subjects in this family. </plain></SENT>
<SENT sid="51" pm="."><plain>For all affected individuals of these two families, carriers of MSH6 frameshift mutations or not, the other MMR genes (MLH3, MSH3 and PMS2) were sequenced, but no mutations were identified. </plain></SENT>
<SENT sid="52" pm="."><plain>Mutiplex Ligation Probe Ampification (MLPA) analysis of MLH1, MSH2, MSH6 and PMS2 in these individuals showed no deletions or duplications [23]. </plain></SENT>
</text></p></sec></SecTag><SecTag type="DISCUSS"><sec id="sec3-ijms-18-00999"><title><text><SENT sid="53" pm="."><plain>3. </plain></SENT>
<SENT sid="54" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="55" pm="."><plain>Data from the literature showed that approximately 10% of families with LS were associated with mutations in MSH6 [5]. </plain></SENT>
<SENT sid="56" pm="."><plain>In this study, we performed mutation analysis of MSH6 in 97 patients with CRC belonging to 74 families selected by the AC and BG. </plain></SENT>
<SENT sid="57" pm="."><plain>For all patients that fulfilled the revised BG, an MSI analysis was performed using DNA extracted from tumor tissues. </plain></SENT>
<SENT sid="58" pm="."><plain>We identified 27 genetic variants, of which nine are novel. </plain></SENT>
<SENT sid="59" pm="."><plain>To identify the pathogenic effect of these novel variants, we used a multivariate analysis, as described in our previous studies [7,21]. </plain></SENT>
<SENT sid="60" pm="."><plain>In silico analysis showed a possible pathogenic effect for seven of the nine novel variants identified MSH6 (Table 2). </plain></SENT>
<SENT sid="61" pm="."><plain>Segregation analysis, which is critical to understanding the contribution of a mutation to disease, does not always confirm computational data. </plain></SENT>
<SENT sid="62" pm="."><plain>Where it was possible, the segregation analysis was performed not only for novel variants, but for each variant identified in this study to verify the association with disease (Table 2). </plain></SENT>
<SENT sid="63" pm="."><plain>Interestingly, the novel variants, c.457+33_+34insGTGT, c.2049_2050insAGT and c.2941A&gt;G, which were predicted to be pathogenic by in silico analysis, were also found to segregate with disease in their families (Figure 1). </plain></SENT>
<SENT sid="64" pm="."><plain>These three variants do not create a truncated protein, but probably alter the MSH6 protein, making it nonfunctional. </plain></SENT>
<SENT sid="65" pm="."><plain>However, the novel frame-shift variants (c.3296_97delTT in exon 5 of the MSH6 gene) that yield a truncated protein were not found to segregate with a Lynch phenotype in either of their families. </plain></SENT>
<SENT sid="66" pm="."><plain>The novel frameshift mutation, c.3296_97delTT, was identified in a patient who developed colon cancer and belongs to a family that fulfilled the AC (Figure 2a). </plain></SENT>
<SENT sid="67" pm="."><plain>It was not possible to perform IHC on tumor tissue from this patient, but we were able to perform MSI analysis on tumor DNA, which showed a strong mutator phenotype. </plain></SENT>
<SENT sid="68" pm="."><plain>The same result was obtained from DNA extracted from colon tumor tissue from a cousin (II:6, Figure 2a) of our index case who was not a carrier of the MSH6 mutation. </plain></SENT>
<SENT sid="69" pm="."><plain>Moreover, the sister and brother of our index case were not carriers of the frameshift variant; however, the sister developed a colon adenoma with a high degree of dysplasia at age 31, while the brother developed polyps at age 49. </plain></SENT>
<SENT sid="70" pm="."><plain>Therefore, we performed mutation detection analysis of other MMR genes (MLH3, MSH3 and PMS2) for the index case and for all affected non-MSH6 carriers belonging to the family. </plain></SENT>
<SENT sid="71" pm="."><plain>These patients were already known to be negative for mutations in MLH1 and MSH2. </plain></SENT>
<SENT sid="72" pm="."><plain>No pathogenic mutations were identified. </plain></SENT>
<SENT sid="73" pm="."><plain>MLPA analysis of MLH1, MSH2, MSH6 and PMS2 in these individuals also showed no rare deletions or duplications [23]. </plain></SENT>
<SENT sid="74" pm="."><plain>Another frameshift mutation, c.3261dup, already described in the literature as pathogenic [22], was identified in our patient who developed colon cancer at age 61. </plain></SENT>
<SENT sid="75" pm="."><plain>This variant was not identified in the sister of the index case who developed two colon adenomas with severe dysplasia at age 63. </plain></SENT>
<SENT sid="76" pm="."><plain>We have not analyzed the other affected members of the family because they had died at diagnosis (Figure 2b). </plain></SENT>
<SENT sid="77" pm="."><plain>For this case, it was possible to perform IHC on paraffin-embedded tumor tissue from the index case. </plain></SENT>
<SENT sid="78" pm="."><plain>This analysis was negative for MSH6 protein expression (Figure 3), and MSI analysis showed MSI-L. </plain></SENT>
<SENT sid="79" pm="."><plain>Analysis of other MMR genes did not show pathogenic mutations. </plain></SENT>
</text></p><p><text><SENT sid="80" pm="."><plain>Therefore, the MSH6 frameshift variants in these two families could be not explain the onset of all cancers and/or adenomas, as other different genetic variants could be responsible for the LS phenotype observed in these families. </plain></SENT>
</text></p><p><text><SENT sid="81" pm="."><plain>It is known that other Mendelian syndromes with autosomal-dominant inheritance patterns show an overlapping clinical presentation with LS. </plain></SENT>
<SENT sid="82" pm="."><plain>In this regard, in previous study by our group, one patient with a Lynch-like phenotype, negative for mutations in MMR genes, showed a germline mutation in PTEN [24], which was associated with disease in the family. </plain></SENT>
<SENT sid="83" pm="."><plain>Sometimes, also tumors with MSI-H status have shown germline genetic variants in genes, such as POLE and POLD1 [25], MYH [26] and also in PTEN [27], beyond MMR variants. </plain></SENT>
</text></p><p><text><SENT sid="84" pm="."><plain>However, these two variants identified in MSH6 create a truncated protein, and thus, it is tempting to assume that there is an effect of these alterations. </plain></SENT>
<SENT sid="85" pm="."><plain>It remains unclear whether these two truncating mutations truly initiate tumorigenesis. </plain></SENT>
<SENT sid="86" pm="."><plain>Interestingly, in our study, the missense mutations and in-frame insertions were found to segregate with disease in carriers in the families and index-cases, and these mutations showed a typical LS phenotype with MSH-H. </plain></SENT>
</text></p><p><text><SENT sid="87" pm="."><plain>It is known that the MSH2-MSH6 complex recognizes both base:base and single base insertion/deletion mismatches, whereas the MSH2-MSH3 complex insertion/deletion mismatches [28,29]. </plain></SENT>
<SENT sid="88" pm="."><plain>The major role of the MSH2-MSH6 complex also justifies the relative abundance compared to the MSH2-MSH3 complex in several species, such as yeast, human and mouse [30]. </plain></SENT>
</text></p><p><text><SENT sid="89" pm="."><plain>Almost 20 years ago, Edelmann et al. showed that mice homozygous for missense mutations in MSH6 were unable to repair any type of defect, because the mutated protein competes with the wild-type protein in the formation of the MSH2-MSH6 complex [31]. </plain></SENT>
<SENT sid="90" pm="."><plain>Meanwhile, subsequent studies have shown that truncated proteins caused by frameshift mutations yielded a weak mutator phenotype [32]. </plain></SENT>
<SENT sid="91" pm="."><plain>This suggested that tumors with missense mutations in MSH6 show a more severe phenotype because the presence of mutant MSH6 protein in tumor cells interferes with MSH2-MSH3-mediated repair. </plain></SENT>
<SENT sid="92" pm="."><plain>In contrast, a lack of MSH6 protein does not interfere with the function of the MSH2-MSH3 heterodimer. </plain></SENT>
<SENT sid="93" pm="."><plain>In cases where MSH6 is not expressed (null mutations), a severe phenotype, if present, is likely to be due to a secondary mutation in an MMR gene, such as MSH3. </plain></SENT>
<SENT sid="94" pm="."><plain>Taking previous data into consideration, the MSH6 variants could be responsible for part of the LS phenotype, and additional genetic factors could lead to the disease either by themselves or in combination with the MSH6 mutations; thus operating in a di- or even multi-genic model [7,33,34]. </plain></SENT>
<SENT sid="95" pm="."><plain>The theory of oligogenic disease would also explain the generally variable onset and severity, as well as the reduced penetrance between and within MSH6 families. </plain></SENT>
<SENT sid="96" pm="."><plain>Interestingly, the index Case 210 of Family 26 was a carrier of two MSH6 variants: the missense variant, c.2941A&gt;G, also identified in her brother (Figure 1b), and the silent variant, c.1395A&gt;T, that was not associated with disease in the family. </plain></SENT>
<SENT sid="97" pm="."><plain>Perhaps for this reason, this subject showed a severe phenotype compared to the other affected members in the family. </plain></SENT>
</text></p><p><text><SENT sid="98" pm="."><plain>In summary, we present several variants in MSH6. </plain></SENT>
<SENT sid="99" pm="."><plain>The mutations that do not delete the protein seem to be associated with a typical LS phenotype, while incomplete segregation of two MSH6 frameshift variants in two independent families may suggest that additional genetic factors are involved in the etiology of the disease, possibly acting as an oligogenic model. </plain></SENT>
<SENT sid="100" pm="."><plain>High-throughput sequencing technologies may help to uncover the genetic basis of LS in the families described in this report [35]. </plain></SENT>
</text></p><p><text><SENT sid="101" pm="."><plain>Genetic counseling and specialized monitoring of families with inherited forms of LS is crucial. </plain></SENT>
<SENT sid="102" pm="."><plain>Identification of a causal gene in the family will have implications for screening and endoscopic surveillance [1,2,36,37]. </plain></SENT>
<SENT sid="103" pm="."><plain>Therefore, family members who do not carry these MSH6 frameshift variants cannot be considered healthy and should still participate in specialized surveillance programs. </plain></SENT>
<SENT sid="104" pm="."><plain>Finally, this study remarks that segregation analysis remains a very important tool in clinical genetics. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="sec4-ijms-18-00999"><title><text><SENT sid="105" pm="."><plain>4. </plain></SENT>
<SENT sid="106" pm="."><plain>Patients and Methods </plain></SENT>
</text></title><sec id="sec4dot1-ijms-18-00999" sec-type="subjects"><title><text><SENT sid="107" pm="."><plain>4.1. </plain></SENT>
<SENT sid="108" pm="."><plain>Patients </plain></SENT>
</text></title><p><text><SENT sid="109" pm="."><plain>The patients were recruited from several hospitals in Campania (Southern Italy). </plain></SENT>
<SENT sid="110" pm="."><plain>Seventy-four subjects with Lynch syndrome diagnosed by the AC or BG and negative for mutations in MLH1 and MSH2 were selected. </plain></SENT>
<SENT sid="111" pm="."><plain>As negative controls, 100 samples from healthy Caucasian patients were collected from the Clinical Department of Laboratory Medicine of the hospital affiliated with Federico II University (Naples, Italy). </plain></SENT>
</text></p><p><text><SENT sid="112" pm="."><plain>Samples from all subjects were collected after being granted authorization from the local ethics committee “Comitato etico per le attività Biomediche Carlo Romano” of the University of Naples, Federico II (Protocol No. 120/10; Date: 15 September 2010). </plain></SENT>
<SENT sid="113" pm="."><plain>Once the authorization was obtained, the study received ethical approval, and participants’ informed and written consent was obtained. </plain></SENT>
<SENT sid="114" pm="."><plain>The experiments were performed on DNA extracted from peripheral blood lymphocytes and from paraffin-embedded tumor tissues. </plain></SENT>
<SENT sid="115" pm="."><plain>For the healthy samples, DNA was extracted only from peripheral blood lymphocytes. </plain></SENT>
</text></p></sec><sec id="sec4dot2-ijms-18-00999"><title><text><SENT sid="116" pm="."><plain>4.2. </plain></SENT>
<SENT sid="117" pm="."><plain>Isolation of Genomic DNA </plain></SENT>
</text></title><p><text><SENT sid="118" pm="."><plain>Total genomic DNA was extracted from 4 mL peripheral blood lymphocytes using a BACC2 Nucleon kit (Amersham Pharmacia Biotech, Amersham, UK). </plain></SENT>
<SENT sid="119" pm="."><plain>For each paraffin block, five 20-μm sections were cut and collected in a 1.5-mL micro-tube. </plain></SENT>
<SENT sid="120" pm="."><plain>DNA was extracted after deparaffinization according to the protocol described by Duraturo et al., 2015, and using a BACC2 Nucleon kit (Amersham Pharmacia Biotech) [38]. </plain></SENT>
</text></p></sec><sec id="sec4dot3-ijms-18-00999"><title><text><SENT sid="121" pm="."><plain>4.3. </plain></SENT>
<SENT sid="122" pm="."><plain>DNA Amplification and Microsatellite Analysis </plain></SENT>
</text></title><p><text><SENT sid="123" pm="."><plain>MSI was tested on paired samples of lymphocyte DNA and DNA from paraffin-embedded tumor sections. </plain></SENT>
<SENT sid="124" pm="."><plain>MSI was evaluated with a fluorescent multiplex system comprising five mononucleotide repeats (BAT-25, BAT-26, NR-21, NR-24 and NR-27), three dinucleotide repeats (D2S123, D5S346 and D17S250) and two tetranucleotide repeats using the CC-MSI kit (AB ANALITICA, Padova, Italy) and subsequent capillary electrophoresis analysis using an ABI 3130 Prism (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA). </plain></SENT>
<SENT sid="125" pm="."><plain>Tumors were classified as “highly unstable” (MSI-H), if at least 30% of the markers showed instabilities, and as “low-level instability” (MSI-L), if at least 10% of the markers showed instabilities; if no allele differences between DNA extracted from normal and tumorous tissues were observed, tumors were classified as microsatellite stable (MSS) [39,40,41]. </plain></SENT>
</text></p></sec><sec id="sec4dot4-ijms-18-00999"><title><text><SENT sid="126" pm="."><plain>4.4. </plain></SENT>
<SENT sid="127" pm="."><plain>Mutation Analysis </plain></SENT>
</text></title><p><text><SENT sid="128" pm="."><plain>Amplification, denaturing high-performance liquid chromatography (dHPLC) and sequencing were all performed using standard protocols. </plain></SENT>
<SENT sid="129" pm="."><plain>All MSH6 exons were amplified, including intron-exon boundaries, from DNA extracted from blood lymphocytes of 97 patients, using customized primer sets. </plain></SENT>
<SENT sid="130" pm="."><plain>Prior to dHPLC analysis, the polymerase chain reaction (PCR) products were separated on a 1–2% agarose gel to check for unspecific amplicons. </plain></SENT>
<SENT sid="131" pm="."><plain>A Transgenomic Wave DNA Fragment Analysis system (3500 HT; Transgenomic, Inc., Omaha, NE, USA) was used to perform dHPLC analysis. </plain></SENT>
<SENT sid="132" pm="."><plain>For all samples exhibiting abnormal dHPLC profiles, genomic DNA was re-amplified and sequenced in the forward and reverse directions using an ABI 3100 Genetic Analyser (Applied Biosystems). </plain></SENT>
</text></p></sec><sec id="sec4dot5-ijms-18-00999"><title><text><SENT sid="133" pm="."><plain>4.5. </plain></SENT>
<SENT sid="134" pm="."><plain>In Silico Analysis </plain></SENT>
</text></title><p><text><SENT sid="135" pm="."><plain>Structural analysis of point variants is important to understand the functional activity of the mutated protein. </plain></SENT>
<SENT sid="136" pm="."><plain>We used three complementary algorithms for functional impact prediction of the novel variants: Sorting Intolerant From Tolerant (SIFT) (available online: http://blocks.fhcrc.org/sift/SIFT.html) [42], Polymorphism Phenotyping (PolyPhen) (available online: http://genetics.bwh.harvard.edu/pph/) [43] and Human Splicing Finder (HSF) (available online: http://www.umd.be/HSF/) [44], as described in our previous studies [7,38]. </plain></SENT>
</text></p></sec><sec id="sec4dot6-ijms-18-00999"><title><text><SENT sid="137" pm="."><plain>4.6. </plain></SENT>
<SENT sid="138" pm="."><plain>Immunohistochemistry </plain></SENT>
</text></title><p><text><SENT sid="139" pm="."><plain>IHC was performed on a Benchmark XT automatized immunostainer (Ventana Medical Biosystems, Tucson, AZ, USA). </plain></SENT>
<SENT sid="140" pm="."><plain>The antibodies used were anti-MSH6, mouse monoclonal clone 44, anti-MSH2, mouse monoclonal clone G219-1129, and anti-MLH1, mouse monoclonal clone M1 (Ventana Medical Biosystems). </plain></SENT>
<SENT sid="141" pm="."><plain>The detection system used was an iVIEW DAB Detection Kit (Ventana Medical Biosystems), which is based on the streptavidin-biotin-conjugated system. </plain></SENT>
<SENT sid="142" pm="."><plain>Nuclear staining was observed with an optical microscope positivity represented by the presence of brown staining. </plain></SENT>
<SENT sid="143" pm="."><plain>This positivity was compared with blue nuclear epitopes, in which the specific antigen was not present. </plain></SENT>
<SENT sid="144" pm="."><plain>The internal positive control was represented by lymphocytes, stroma and functional mucosal crypts, while the negative control was obtained by slides without primary antibody. </plain></SENT>
<SENT sid="145" pm="."><plain>Nuclear immunoreactivity scores were assigned using range from 0–100%. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="CONCL"><sec id="sec5-ijms-18-00999"><title><text><SENT sid="146" pm="."><plain>5. </plain></SENT>
<SENT sid="147" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="148" pm="."><plain>In this study, we have identified nine novel variants in MSH6 gene which enlarge the mutation spectrum of this gene. </plain></SENT>
<SENT sid="149" pm="."><plain>Furthermore, the incomplete segregation of two MSH6 variants in two independent families may suggest that additional genetic factors are involved in the etiology of the disease, possibly acting as an oligogenic model. </plain></SENT>
<SENT sid="150" pm="."><plain>Finally, our data showed that segregation analysis remains important in clinical genetics. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><title>Acknowledgments</title><p><text4fund><text><SENT sid="151" pm="."><plain>This study has been supported by the agreement 2010–2012 between CEINGE-Biotecnologie Avanzate and Campania Regional Authority; POR-Campania FSE2007–2013. </plain></SENT>
</text></text4fund></p></ack></SecTag><notes><title>Author Contributions</title><p>Conceived of and designed the experiments: Francesca Duraturo; Performed the experiments: Francesca Duraturo, Raffaella Liccardo; Analyzed the data: Francesca Duraturo; Wrote the first draft of the manuscript: Francesca Duraturo; Contributed to the writing of the manuscript: Francesca Duraturo, Raffaella Liccardo; Contributed reagents/materials/analysis tools: Marina De Rosa; Giovanni Battista Rossi; Nicola Carlomagno; Agree with the manuscript results and conclusions: Raffaella Liccardo, Marina De Rosa, Giovanni Battista Rossi, Nicola Carlomagno, Paola Izzo, Francesca Duraturo; Made critical revisions and approved final version: Francesca Duraturo and Paola Izzo. All authors reviewed and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflict of interest</title><p>The authors declare no conflicts of interest.</p></notes><SecTag type="REF"><ref-list><title>References</title><ref id="B1-ijms-18-00999"><text><SENT sid="152" pm="."><plain>1.LynchH.T.DrescherK.KnezeticJ.LanspaS.Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: A reviewCurr. </plain></SENT>
<SENT sid="153" pm="."><plain>Treat. </plain></SENT>
<SENT sid="154" pm="."><plain>Options Oncol.20141542944210.1007/s11864-014-0293-5<?supplied-pmid 24827900?>24827900 </plain></SENT>
</text></ref><ref id="B2-ijms-18-00999"><text><SENT sid="155" pm="."><plain>2.De RosaM.PaceU.RegaD.CostabileV.DuraturoF.IzzoP.DelrioP.Genetics, diagnosis and management of colorectal cancer (Review)Oncol. </plain></SENT>
<SENT sid="156" pm="."><plain>Rep.2015341087109610.3892/or.2015.4108<?supplied-pmid 26151224?>26151224 </plain></SENT>
</text></ref><ref id="B3-ijms-18-00999"><text><SENT sid="157" pm="."><plain>3.De RosaM.GalatolaM.BorrielloS.DuraturoF.MasoneS.IzzoP.Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposisDis. </plain></SENT>
<SENT sid="158" pm="."><plain>Colon. </plain></SENT>
<SENT sid="159" pm="."><plain>Rectum.20095226827410.1007/DCR.0b013e318197d15c<?supplied-pmid 19279422?>19279422 </plain></SENT>
</text></ref><ref id="B4-ijms-18-00999"><text><SENT sid="160" pm="."><plain>4.LynchP.M.The hMSH2 and hMLH1 genes in hereditary nonpolyposis colorectal cancerSurg. </plain></SENT>
<SENT sid="161" pm="."><plain>Oncol. </plain></SENT>
<SENT sid="162" pm="."><plain>Clin. </plain></SENT>
<SENT sid="163" pm="."><plain>N. </plain></SENT>
<SENT sid="164" pm="."><plain>Am.20091861162410.1016/j.soc.2009.08.002<?supplied-pmid 19793569?>19793569 </plain></SENT>
</text></ref><ref id="B5-ijms-18-00999"><text><SENT sid="165" pm="."><plain>5.TiwariA.K.RoyH.K.LynchH.T.Lynch syndrome in the 21st century: Clinical perspectivesQJM201610915115810.1093/qjmed/hcv137<?supplied-pmid 26224055?>26224055 </plain></SENT>
</text></ref><ref id="B6-ijms-18-00999"><text><SENT sid="166" pm="."><plain>6.DuraturoF.LiccardoR.IzzoP.Coexistence of MLH3 germline variants in colon cancer patients belonging to families with Lynch syndrome-associated brain tumorsJ. </plain></SENT>
<SENT sid="167" pm="."><plain>Neurooncol.201612957757810.1007/s11060-016-2203-0<?supplied-pmid 27401157?>27401157 </plain></SENT>
</text></ref><ref id="B7-ijms-18-00999"><text><SENT sid="168" pm="."><plain>7.DuraturoF.LiccardoR.CavalloA.de RosaM.GrossoM.IzzoP.Association of low-risk MSH3 and MSH2 variant alleles with Lynch syndrome: Probability of synergistic effectsInt. </plain></SENT>
<SENT sid="169" pm="."><plain>J. </plain></SENT>
<SENT sid="170" pm="."><plain>Cancer20111291643165010.1002/ijc.25824<?supplied-pmid 21128252?>21128252 </plain></SENT>
</text></ref><ref id="B8-ijms-18-00999"><text><SENT sid="171" pm="."><plain>8.SinicropeF.A.SargentD.J.Molecular pathways: Microsatellite instability in colorectal cancer: Prognostic, predictive, and therapeutic implicationsClin. </plain></SENT>
<SENT sid="172" pm="."><plain>Cancer Res.2012181506151210.1158/1078-0432.CCR-11-1469<?supplied-pmid 22302899?>22302899 </plain></SENT>
</text></ref><ref id="B9-ijms-18-00999"><text><SENT sid="173" pm="."><plain>9.PoulogiannisG.FraylingI.M.ArendsM.J.DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndromeHistopathology20105616717910.1111/j.1365-2559.2009.03392.x<?supplied-pmid 20102395?>20102395 </plain></SENT>
</text></ref><ref id="B10-ijms-18-00999"><text><SENT sid="174" pm="."><plain>10.VasenH.F.A.WatsonP.MecklinJ.P.LynchH.T.New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCCGastroenterology19991161453145610.1016/S0016-5085(99)70510-X10348829 </plain></SENT>
</text></ref><ref id="B11-ijms-18-00999"><text><SENT sid="175" pm="."><plain>11.BolandC.R.ThibodeauS.N.HamiltonS.R.SidranskyD.EshlemanJ.R.BurtR.W.MeltzerS.J.Rodriguez-BigasM.A.FoddeR.RanzaniG.N.A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancerCancer Res.19985852485257<?supplied-pmid 9823339?>9823339 </plain></SENT>
</text></ref><ref id="B12-ijms-18-00999"><text><SENT sid="176" pm="."><plain>12.UmarA.BolandC.R.TerdimanJ.P.SyngalS.de la ChapelleA.RüschoffJ.FishelR.LindorN.M.BurgartL.J.HamelinR.Revised bethesda guidelines for hereditary non polyposis colorectal cancer (Lynch Syndrome) and microsatellite instabilityJ. </plain></SENT>
<SENT sid="177" pm="."><plain>Natl. </plain></SENT>
<SENT sid="178" pm="."><plain>Cancer Inst.20049626126810.1093/jnci/djh034<?supplied-pmid 14970275?>14970275 </plain></SENT>
</text></ref><ref id="B13-ijms-18-00999"><text><SENT sid="179" pm="."><plain>13.RubensteinJ.H.EnnsR.HeidelbaughJ.BarkunA.Clinical Guidelines Committee. </plain></SENT>
<SENT sid="180" pm="."><plain>American gastroenterological association institute guideline on the diagnosis and management of Lynch SyndromeGastroenterology201514977778210.1053/j.gastro.2015.07.036<?supplied-pmid 26226577?>26226577 </plain></SENT>
</text></ref><ref id="B14-ijms-18-00999"><text><SENT sid="181" pm="."><plain>14.PalomboF.GallinariP.IaccarinoI.LettieriT.HughesM.D’ArrigoA.TruongO.HsuanJ.J.JiricnyJ.GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cellsScience19952681912191410.1126/science.7604265<?supplied-pmid 7604265?>7604265 </plain></SENT>
</text></ref><ref id="B15-ijms-18-00999"><text><SENT sid="182" pm="."><plain>15.DrummondJ.T.LiG.M.LongleyM.J.ModrichP.Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cellsScience19952681909191210.1126/science.7604264<?supplied-pmid 7604264?>7604264 </plain></SENT>
</text></ref><ref id="B16-ijms-18-00999"><text><SENT sid="183" pm="."><plain>16.EdelmannW.YangK.UmarA.HeyerJ.LauK.FanK.LiedtkeW.CohenP.E.KaneM.F.LipfordJ.R.Mutation in the mismatch repair gene MSH6 causes cancer susceptibilityCell19979146747710.1016/S0092-8674(00)80433-X9390556 </plain></SENT>
</text></ref><ref id="B17-ijms-18-00999"><text><SENT sid="184" pm="."><plain>17.MiyakiM.KonishiM.TanakaK.Kikuchi-YanoshitaR.MuraokaM.YasunoM.IgariTKoikeM.ChibaM.MoriT.Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancerNat. </plain></SENT>
<SENT sid="185" pm="."><plain>Genet.19971727127210.1038/ng1197-271<?supplied-pmid 9354786?>9354786 </plain></SENT>
</text></ref><ref id="B18-ijms-18-00999"><text><SENT sid="186" pm="."><plain>18.Lucci-CordiscoE.RovellaV.CarraraS.PercesepeA.PedroniM.BellacosaA.CaluseriuO.ForasarigM.AntiM.NeriG.Mutations of the “minor” mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancerFam. </plain></SENT>
<SENT sid="187" pm="."><plain>Cancer20011939910.1023/A:1013872914474<?supplied-pmid 14574004?>14574004 </plain></SENT>
</text></ref><ref id="B19-ijms-18-00999"><text><SENT sid="188" pm="."><plain>19.LongQ.PengY.TangZ.WuC.Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome familiesInt. </plain></SENT>
<SENT sid="189" pm="."><plain>J. </plain></SENT>
<SENT sid="190" pm="."><plain>Clin. </plain></SENT>
<SENT sid="191" pm="."><plain>Exp. </plain></SENT>
<SENT sid="192" pm="."><plain>Pathol.2014772977303<?supplied-pmid 25400828?>25400828 </plain></SENT>
</text></ref><ref id="B20-ijms-18-00999"><text><SENT sid="193" pm="."><plain>20.ChuM.M.LiuS.S.TamK.F.IpP.P.CheungA.N.NganH.Y.The significance of mismatch repair deficiency in young patients with endometrial cancerInt. </plain></SENT>
<SENT sid="194" pm="."><plain>J. </plain></SENT>
<SENT sid="195" pm="."><plain>Gynecol. </plain></SENT>
<SENT sid="196" pm="."><plain>Pathol.20153440341010.1097/PGP.0000000000000174<?supplied-pmid 26262451?>26262451 </plain></SENT>
</text></ref><ref id="B21-ijms-18-00999"><text><SENT sid="197" pm="."><plain>21.OuJ.NiessenR.C.VonkJ.WestersHHofstraR.M.W.SijmonsR.H.A database to support the interpretation of human mismatch repair gene variantsHum. </plain></SENT>
<SENT sid="198" pm="."><plain>Mutat.2008291337134110.1002/humu.20907<?supplied-pmid 18951442?>18951442 </plain></SENT>
</text></ref><ref id="B22-ijms-18-00999"><text><SENT sid="199" pm="."><plain>22.BonkT.HumenyA.GebertJ.SutterC.von Knebel DoeberitzM.BeckerC.M.Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based detection of microsatellite instabilities in coding DNA sequences: A novel approach to identify DNA-mismatch repair-deficient cancer cellsClin. </plain></SENT>
<SENT sid="200" pm="."><plain>Chem.20034955256110.1373/49.4.552<?supplied-pmid 12651806?>12651806 </plain></SENT>
</text></ref><ref id="B23-ijms-18-00999"><text><SENT sid="201" pm="."><plain>23.DuraturoF.CavalloA.LiccardoR.CudiaB.de RosaM.DianaG.IzzoP.Contribution of large genomic rearrangements in Italian Lynch syndrome patients: Characterization of a novel alu-mediated deletionBiomed. </plain></SENT>
<SENT sid="202" pm="."><plain>Res. </plain></SENT>
<SENT sid="203" pm="."><plain>Int.2013201321989710.1155/2013/219897<?supplied-pmid 23484096?>23484096 </plain></SENT>
</text></ref><ref id="B24-ijms-18-00999"><text><SENT sid="204" pm="."><plain>24.PaparoL.RossiG.B.DelrioP.RegaD.DuraturoF.LiccardoR.DebellisMIzzoP.de RosaM.Differential expression of PTEN gene correlates with phenotypic heterogeneity in three cases of patients showing clinical manifestations of PTEN hamartoma tumour syndromeHered. </plain></SENT>
<SENT sid="205" pm="."><plain>Cancer Clin. </plain></SENT>
<SENT sid="206" pm="."><plain>Pract.201311810.1186/1897-4287-11-8<?supplied-pmid 23886400?>23886400 </plain></SENT>
</text></ref><ref id="B25-ijms-18-00999"><text><SENT sid="207" pm="."><plain>25.WongA.KuickC.H.WongW.L.ThamJ.M.MansorS.LohE.JainS.VikasN.N.TanS.HChanS.H.Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomasGynecol. </plain></SENT>
<SENT sid="208" pm="."><plain>Oncol.201614111312010.1016/j.ygyno.2015.12.031<?supplied-pmid 26748215?>26748215 </plain></SENT>
</text></ref><ref id="B26-ijms-18-00999"><text><SENT sid="209" pm="."><plain>26.ColebatchA.HitchinsM.WilliamsR.MeagherAHawkinsN.J.WardR.L.The role of MYH and microsatellite instability in the development of sporadic colorectal cancerBr. </plain></SENT>
<SENT sid="210" pm="."><plain>J. </plain></SENT>
<SENT sid="211" pm="."><plain>Cancer2006951239124310.1038/sj.bjc.6603421<?supplied-pmid 17031395?>17031395 </plain></SENT>
</text></ref><ref id="B27-ijms-18-00999"><text><SENT sid="212" pm="."><plain>27.BilbaoC.RodríguezG.RamírezR.FalcónO.LeónLChirinoRRiveroJ.F.FalcónO.Jr.Díaz-ChicoB.N.Díaz-ChicoJ.CThe relationship between microsatellite instability and PTEN gene mutations in endometrial cancerInt. </plain></SENT>
<SENT sid="213" pm="."><plain>J. </plain></SENT>
<SENT sid="214" pm="."><plain>Cancer200611956357010.1002/ijc.21862<?supplied-pmid 16506206?>16506206 </plain></SENT>
</text></ref><ref id="B28-ijms-18-00999"><text><SENT sid="215" pm="."><plain>28.LawesD.A.SenGuptaS.B.BoulosP.B.Pathogenesis and clinical management of hereditary non-polyposis colorectal cancerBr. </plain></SENT>
<SENT sid="216" pm="."><plain>J. </plain></SENT>
<SENT sid="217" pm="."><plain>Surg.2002891357136910.1046/j.1365-2168.2002.02290.x<?supplied-pmid 12390374?>12390374 </plain></SENT>
</text></ref><ref id="B29-ijms-18-00999"><text><SENT sid="218" pm="."><plain>29.JunS.H.KimT.G.BanC.DNA mismatch repair system. </plain></SENT>
<SENT sid="219" pm="."><plain>Classical and fresh rolesFEBS J.20062731609161910.1111/j.1742-4658.2006.05190.x<?supplied-pmid 16623698?>16623698 </plain></SENT>
</text></ref><ref id="B30-ijms-18-00999"><text><SENT sid="220" pm="."><plain>30.WiesendangerM.KneitzB.EdelmannW.ScharffM.D.Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution patternJ. </plain></SENT>
<SENT sid="221" pm="."><plain>Exp. </plain></SENT>
<SENT sid="222" pm="."><plain>Med.2000757958410.1084/jem.191.3.579 </plain></SENT>
</text></ref><ref id="B31-ijms-18-00999"><text><SENT sid="223" pm="."><plain>31.EdelmannW.UmarA.YangK.HeyerJ.KucherlapatiM.LiaM.KneitzB.AvdievichE.FanK.WongE.The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppressionCancer Res.200015803807 </plain></SENT>
</text></ref><ref id="B32-ijms-18-00999"><text><SENT sid="224" pm="."><plain>32.YangG.SchererS.J.ShellS.S.YangK.KimM.LipkinM.KucherlapatiR.KolodnerR.DEdelmannW.Dominant effects of an MSH6 missense mutation on DNA repair and cancer susceptibilityCancer Cell2004613915010.1016/j.ccr.2004.06.024<?supplied-pmid 15324697?>15324697 </plain></SENT>
</text></ref><ref id="B33-ijms-18-00999"><text><SENT sid="225" pm="."><plain>33.MartinezS.L.KolodnerR.D.Functional analysis of human mismatch repair gene mutations identifies weak alleles and polymorphisms capable of polygenic interactionsProc. </plain></SENT>
<SENT sid="226" pm="."><plain>Natl. </plain></SENT>
<SENT sid="227" pm="."><plain>Acad. </plain></SENT>
<SENT sid="228" pm="."><plain>Sci. </plain></SENT>
<SENT sid="229" pm="."><plain>USA20101075070507510.1073/pnas.1000798107<?supplied-pmid 20176959?>20176959 </plain></SENT>
</text></ref><ref id="B34-ijms-18-00999"><text><SENT sid="230" pm="."><plain>34.KumarC.PiacenteS.C.SibertJBukataA.R.O’ConnorJ.AlaniE.SurteesJ.A.Multiple factors insulate Msh2–Msh6 mismatch repair activity from defects in Msh2 domain IJ. </plain></SENT>
<SENT sid="231" pm="."><plain>Mol. </plain></SENT>
<SENT sid="232" pm="."><plain>Biol.201141176578010.1016/j.jmb.2011.06.030<?supplied-pmid 21726567?>21726567 </plain></SENT>
</text></ref><ref id="B35-ijms-18-00999"><text><SENT sid="233" pm="."><plain>35.Talseth-PalmerB.A.BauerD.C.SjursenW.EvansT.J.McPhillipsM.ProiettoA.OttonG.SpigelmanA.D.ScottR.J.Targeted next-generation sequencing of 22 mismatch repair genes identifies Lynch syndrome familiesCancer Med.2016592994110.1002/cam4.628<?supplied-pmid 26811195?>26811195 </plain></SENT>
</text></ref><ref id="B36-ijms-18-00999"><text><SENT sid="234" pm="."><plain>36.CarethersJ.M.StoffelE.M.Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancerWorld J. </plain></SENT>
<SENT sid="235" pm="."><plain>Gastroenterol.2015219253926110.3748/wjg.v21.i31.9253<?supplied-pmid 26309352?>26309352 </plain></SENT>
</text></ref><ref id="B37-ijms-18-00999"><text><SENT sid="236" pm="."><plain>37.CudiaB.LiccardoR.di CarloG.DamianoGLo MonteA.I.IzzoPDuraturoF.Clinical and anamnestic evaluation role for the diagnosis and treatment of families affected by Lynch syndrome. </plain></SENT>
<SENT sid="237" pm="."><plain>Case report and review of the literatureEur. </plain></SENT>
<SENT sid="238" pm="."><plain>J. </plain></SENT>
<SENT sid="239" pm="."><plain>Oncol.201519265271 </plain></SENT>
</text></ref><ref id="B38-ijms-18-00999"><text><SENT sid="240" pm="."><plain>38.DuraturoF.LiccardoR.CavalloA.de RosaMRossiG.B.IzzoP.Multivariate analysis as a method for evaluating the pathogenicity of novel genetic MLH1 variants in patients with colorectal cancer and microsatellite instabilityInt. </plain></SENT>
<SENT sid="241" pm="."><plain>J. </plain></SENT>
<SENT sid="242" pm="."><plain>Mol. </plain></SENT>
<SENT sid="243" pm="."><plain>Med.20153651151710.3892/ijmm.2015.2255<?supplied-pmid 26096739?>26096739 </plain></SENT>
</text></ref><ref id="B39-ijms-18-00999"><text><SENT sid="244" pm="."><plain>39.SuraweeraN.DuvalA.ReperantM.VauryC.FurlanD.LeroyK.SerucaR.IacopettaB.HamelinR.Evaluation of tumor microsatellite instability using five quasimonomorphic nucleotide repeats and pentaplex PCRGastroenterology20021231804181110.1053/gast.2002.37070<?supplied-pmid 12454837?>12454837 </plain></SENT>
</text></ref><ref id="B40-ijms-18-00999"><text><SENT sid="245" pm="."><plain>40.XicolaR.M.LlorX.PonsECastellsA.AlendaC.PiñolV.AndreuM.Castellví-BelS.PayáA.JoverR.Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors gastrointestinal oncology group of the Spanish gastroenterological associationJ. </plain></SENT>
<SENT sid="246" pm="."><plain>Natl. </plain></SENT>
<SENT sid="247" pm="."><plain>Cancer Inst.20079924425210.1093/jnci/djk033<?supplied-pmid 17284719?>17284719 </plain></SENT>
</text></ref><ref id="B41-ijms-18-00999"><text><SENT sid="248" pm="."><plain>41.VilarE.MorkM.E.CuddyA.BorrasE.BannonS.A.TaggartM.W.YingJ.BroaddusR.R.LuthraR.Rodriguez-BigasM.A.Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancerCancer Genet.201420749550210.1016/j.cancergen.2014.10.002<?supplied-pmid 25432668?>25432668 </plain></SENT>
</text></ref><ref id="B42-ijms-18-00999"><text><SENT sid="249" pm="."><plain>42.KumarP.HenikoffS.NgP.C.Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmNat. </plain></SENT>
<SENT sid="250" pm="."><plain>Protoc.200941073108110.1038/nprot.2009.86<?supplied-pmid 19561590?>19561590 </plain></SENT>
</text></ref><ref id="B43-ijms-18-00999"><text><SENT sid="251" pm="."><plain>43.AdzhubeiI.JordanD.M.SunyaevS.R.Predicting functional effect of human missense mutations using PolyPhen-2Curr. </plain></SENT>
<SENT sid="252" pm="."><plain>Protoc. </plain></SENT>
<SENT sid="253" pm="."><plain>Hum. </plain></SENT>
<SENT sid="254" pm="."><plain>Genet.20137720 </plain></SENT>
</text></ref><ref id="B44-ijms-18-00999"><text><SENT sid="255" pm="."><plain>44.DesmetF.O.HamrounD.LalandeM.Collod-BeroudG.ClaustresM.BeroudC.Human splicing finder: An online bioinformatics tool to predict splicing signalsNucleic Acids Res.200937e6710.1093/nar/gkp215<?supplied-pmid 19339519?>19339519 </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-group><SecTag type="FIG"><fig id="ijms-18-00999-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p><text><SENT sid="256" pm="."><plain>(a) Family 33: pedigree of index case (ID 409) carrier intronic variant c.457+33_+34insGTGT in exon 2 of MSH6 gene; (b) Family 26: pedigree of the index case (ID 210) carrier missense variant c.1395 A&gt;T in exon 4 of the MSH6 gene; (c) Family 102: pedigree of the index case (ID 1454) carrier in the frame variant c.2049_2050insAGT in exon 5 of the MSH6 gene. </plain></SENT>
<SENT sid="257" pm="."><plain>Symbols and abbreviations used are denoted as follows: arrow, index case; black symbol, cancers or colon adenomas associated with LS; Co, colon cancer; Ad, adenoma with moderate dysplasia; Hp, hyperplastic polyps; Bla, bladder cancer; Pro, prostate cancer. </plain></SENT>
<SENT sid="258" pm="."><plain>The number next to the diagnosis denotes age at onset. * Denotes family members are carriers of a specific variant. </plain></SENT>
</text></p></caption><graphic xlink:href="ijms-18-00999-g001"/></fig></SecTag><SecTag type="FIG"><fig id="ijms-18-00999-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p><text><SENT sid="259" pm="."><plain>(a) Family 21 pedigree of the index case (ID 105) carrier of novel frameshift variant, c. </plain></SENT>
<SENT sid="260" pm="."><plain>3296_97delTT in exon 5 of the MSH6 gene; (b) Family pedigree of the index case (ID 103) carrier of known frameshift variant c. </plain></SENT>
<SENT sid="261" pm="."><plain>3261dupC in exon 5 of the MSH6 gene. </plain></SENT>
<SENT sid="262" pm="."><plain>Symbols and abbreviations used are denoted as follows: arrows, index case; black symbol, cancers or colon adenomas associated with LS; Co, colon cancer; CoR, colorectal cancer; Ga, gastric cancer; End, endometrial cancer; Ad, adenoma with severe dysplasia; HP, hyperplastic polyps. </plain></SENT>
<SENT sid="263" pm="."><plain>Numbers next to the diagnosis denote age at onset;  Analysed members that were not carried of mutation. </plain></SENT>
</text></p></caption><graphic xlink:href="ijms-18-00999-g002"/></fig></SecTag><SecTag type="FIG"><fig id="ijms-18-00999-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p><text><SENT sid="264" pm="."><plain>MSH6, MSH2 and MLH1 immunohistochemistry (IHC) results in the colon tumor section of the index Case 103 carrier of the c.3261dup variant in MSH6 exon 5. </plain></SENT>
<SENT sid="265" pm="."><plain>(a) Absence of MSH6 protein in the tumor cells; (b) normal IHC for MSH2 protein in the tumor cells; (c) normal IHC for MLH1 protein in the tumor cells. </plain></SENT>
<SENT sid="266" pm="."><plain>Arrows point to IHC− tumor cells; filled arrow heads point to IHC+ tumor cells; open arrow heads point to blue nuclear staining of lymphocytes (positive internal control). </plain></SENT>
</text></p></caption><graphic xlink:href="ijms-18-00999-g003"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="ijms-18-00999-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-18-00999-t001_Table 1</object-id><label>Table 1</label><caption><p><text><SENT sid="267" pm="."><plain>Variants identified in the MSH6 gene in our study. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="268" pm="."><plain>Exon </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="269" pm="."><plain>Nucleotide Change </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="270" pm="."><plain>Amino Acid Change </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="271" pm="."><plain>Frequency in Hereditary CRC </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="272" pm="."><plain>Reference (Reportage) </plain></SENT>
</text></th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="273" pm="."><plain>Other Studies </plain></SENT>
</text></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>Segregation Analysis </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>MSI </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>IHC </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>1 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>c.116 G&gt;A </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>p.Gly39Glu </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>42 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>dbSNP-rs1042821 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>1 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>c.186 A&gt;C </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>p. = (Arg) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>40 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>Nicolaides et al. </plain></SENT>
<SENT sid="290" pm="."><plain>1996 (29 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>1 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>c.260 +22 C&gt;G </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>29 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>Kolodner et al. </plain></SENT>
<SENT sid="298" pm="."><plain>1999 (8 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>c.261 −46 A&gt;G </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>this study </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>c.276 A&gt;G </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>p. = (Pro) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>20 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>dbSNP-rs1800932 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>c.431 G&gt;T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>p.Ser144Ile </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>Wu et al. </plain></SENT>
<SENT sid="322" pm="."><plain>1999 (26 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>c.457 +33_+34insGTGT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>Identified in this study </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>(+) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>MSI-L </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>c.457 +50 T&gt;A </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>Identified in this study </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>c.457 +52 T&gt;A </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>3 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>Plaschke et al. </plain></SENT>
<SENT sid="344" pm="."><plain>2000 (25 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>ND; ND; MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>c.540 T&gt;C </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>p. = (Asp) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>11 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>dbSNP-rs1800935 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>c.642 C&gt;T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>p. = (Tyr) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>6 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>Wijnen et al. </plain></SENT>
<SENT sid="361" pm="."><plain>1999 (26 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>c.663 A&gt;C </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>p.Glu221Asp </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>Devlin et al. </plain></SENT>
<SENT sid="370" pm="."><plain>2008 (7 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>c.990 A&gt;T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>p. = (Ser) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>Identified in this study </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>c.1164 C&gt;T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>p. = (His) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>Kolodner et al. </plain></SENT>
<SENT sid="387" pm="."><plain>1999 (4 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>(−) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>c.1395 A&gt;T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>p. = (Ala) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>Identified in this study </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>(−) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>c.2049_2050insAGT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>p.Ala683_Leu684insSer </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>Identified in this study </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>(+) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>MSH6-; MSH2+; MLH1+ </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>c.2398 G&gt;C </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>p.Val800Leu </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>Kolodner et al. </plain></SENT>
<SENT sid="412" pm="."><plain>1999 (3 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>(+) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>c.2633 T&gt;C </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>p.Val878Ala </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>2 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>dbSNP-rs2020912 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>MSI-H, ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>c.2941 A&gt;G </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>p.Ile981Val </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>Identified in this study </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>(+) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>5 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>c.3226 C&gt;T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>p.Arg1076Cys </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>Plaschke et al. </plain></SENT>
<SENT sid="437" pm="."><plain>2000 (8 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>5 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>c.3261dup </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>p.Phe1088Argfs*3 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>Bonk et al. (2 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>(−) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>MSI-L </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>MSH6-; MSH2+; MLH1+ </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>5 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>c.3296_3297delTT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>p.Ile1099delinsAsnfs*8 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>Identified in this study </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>(−) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>5 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>c.3438 +14 A&gt;T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>15 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>dbSNP-rs2020911 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>7 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>c.3639 T&gt;A </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>p.Asp1214Glu </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>1 family </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>Identified in this study </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>7 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>c.3646 +31_+34del </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>16 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>dbSNP-rs1805181 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>8_9 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>c.3802−42insT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>4 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>Plaschke et al. </plain></SENT>
<SENT sid="483" pm="."><plain>2000 (2 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>ND; ND; ND; ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>8_9 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>c.3801 +54C&gt;G </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>8 families </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>Kolodner et al. </plain></SENT>
<SENT sid="491" pm="."><plain>1999 (10 times) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>ND </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>NCBI accession number: NM000179; CRC: colorectal cancer; ND: not done; MSI-L/H: low/high microsatellite instability; IHC: immunohistochemistry.</p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="ijms-18-00999-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-18-00999-t002_Table 2</object-id><label>Table 2</label><caption><p><text><SENT sid="495" pm="."><plain>Novel MSH6 variants identified in this study. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="496" pm="."><plain>Family </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="497" pm="."><plain>ID </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="498" pm="."><plain>Mutation </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="499" pm="."><plain>Protein Effect </plain></SENT>
</text></th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="500" pm="."><plain>In Silico Analysis </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="501" pm="."><plain>Frequency in Healthy Controls </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="502" pm="."><plain>Phenotype MSI </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="503" pm="."><plain>Segregation Analysis in Affected Subjects </plain></SENT>
</text></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>PolyPhen (Score) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>SIFT (Score) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>HSF </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>31 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>808 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>Ex2 c.261 -46 A&gt;G </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>+3’ss;  +BP </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>0/100 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>AM−;  ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>33 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>409 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>Ex2 c.457+33_+34insGTGT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>+3’ss × 2;  +ESE </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>0/100 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>AM−;  MSI-L </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>3/3 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>10 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>9529 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>Ex2 c.457 +50 T&gt;A </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>+3’ss </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>0/100 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>AM+;  MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>34 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>410 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>Ex4 c.990 A&gt;T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>p. = (Ser) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>−SRp55;  −EIE </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>0/100 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>AM+;  MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>ND </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>26 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>210 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>Ex4 c.1395 A&gt;T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>p. = (Ala) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>−SRp55;  +ESS × 2;  +ESR </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>2/100 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>AM+;  MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>1/2 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>102 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>1454 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="556" pm="."><plain>Ex4 c.2049_2050insAGT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>p.Ala683_Leu684insSer </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="558" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>+3’ss × 2;  +BP </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="561" pm="."><plain>0/100 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>AM−;  MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>2/2 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>26 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>210 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="566" pm="."><plain>Ex4 c.2941 A&gt;G </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="567" pm="."><plain>p.Ile981Val </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="568" pm="."><plain>Benign (0.181) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="569" pm="."><plain>Tolerated (1) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="570" pm="."><plain>+3’ss;  +ESE × 2;  −EIE × 2;  +ESS;  +9G8;  +ESR </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="571" pm="."><plain>0/100 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="572" pm="."><plain>AM+;  MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="573" pm="."><plain>2/2 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="574" pm="."><plain>21 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="575" pm="."><plain>105 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="576" pm="."><plain>Ex5 c.3296_97delTT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="577" pm="."><plain>p.Ile1099delinsAsnfs*8 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="578" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="579" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="580" pm="."><plain>ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="581" pm="."><plain>0/100 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="582" pm="."><plain>AM+;  MSI-H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="583" pm="."><plain>1/4 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="584" pm="."><plain>18 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="585" pm="."><plain>013 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="586" pm="."><plain>Ex7 c.3639 T&gt;A </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="587" pm="."><plain>p.Asp1214Glu </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="588" pm="."><plain>Probably damaging (1) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="589" pm="."><plain>Damaging (0) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="590" pm="."><plain>+3’ss × 2;  +ESE × 5;  +EIE;  +Tra2β;  −IIE × 3;  +ESR </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="591" pm="."><plain>0/100 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="592" pm="."><plain>AM+;  ND </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="593" pm="."><plain>ND </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>ID: identification number patient; AM: Amsterdam Criteria; MSI-L/H: low/high microsatellite instability; ND: not done; motifs identified (+) or broken (−) by HSF (Human Splicing Finder): 3’ss, acceptor cryptic splice site; BP: branch point; ESE: exonic splicing enhancer; EIE: exon identity element; ESS: exonic splicing silencer; ESR: exonic splicing regulatory; IIE: intron identity element; SRp55, 9G8 and Tra2β: splicing enhancer proteins; SIFT: Sorting Intolerant From Tolerant. When multiple adjacent sites were predicted, the number of sites is indicated: ×2 means that two adjacent sites were modified by the mutation.</p></fn></table-wrap-foot></table-wrap></SecTag></floats-group></article>
